Repurposing clinically approved antibacterial drugs for treponematoses therapy

Project description

Evaluation of antibacterial treatment options for treponematoses therapy

Fields of science

• natural sciences › biological sciences › neurobiology
• natural sciences › biological sciences › microbiology › bacteriology
• natural sciences › biological sciences › genetics › mutation
• medical and health sciences › basic medicine › pharmacology and pharmacy › pharmaceutical drugs › antibiotics
• medical and health sciences › clinical medicine › allergology

Programme(s)

• H2020-EU.1.1. - EXCELLENT SCIENCE - European Research Council (ERC) Main Programme

Topic(s)

• ERC-2019-STG - ERC Starting Grant

Call for proposal

ERC-2019-STG

See other projects for this call

Funding Scheme

ERC-STG - Starting Grant

Host institution

FUNDACION FILS DE LUCHA CONTRA ELSIDA LAS ENFERMEDADES INFECCIOSASY LA PROMOCION DE LA SALUD Y LACIENCIA

Net EU contribution

€ 1 150 678,81

Address

Carretera De Canyet Hospital Germans Trias I Pujol Planta 2
08916 Badalona
Spain

Region

Este › Cataluña › Barcelona

Activity type

Research Organisations

Links

Other funding

€ 0,00

Beneficiaries (2)

FUNDACION FILS DE LUCHA CONTRA ELSIDA LAS ENFERMEDADES INFECCIOSASY LA PROMOCION DE LA SALUD Y LACIENCIA

Spain

Net EU contribution

€ 1 150 678,81

Address

Carretera De Canyet Hospital Germans Trias I Pujol Planta 2
08916 Badalona

Region

Este › Cataluña › Barcelona

Activity type

Research Organisations

Links

Other funding

€ 0,00

UNIVERSITY OF WASHINGTON

United States

Net EU contribution

€ 348 111,19

Address

Brooklyn Avenue Ne 4333
98195 9472 Seattle Wa

Activity type

Higher or Secondary Education Establishments

Links

Other funding

€ 0,00